News Releases

OHC medical oncologist Dr. Randy Drosick recently was interviewed by Cumulus WGRR (103.5 FM) host Janeen Coyle on the topic of breast cancer. To view this video, please CLICK HERE. OHC is leading the fight against breast cancer with targeted therapy   (Read More)

OHC representatives Dr. Randy Broun and Brian Bourbeau are meeting with the offices of Senators Sherrod Brown, Rob Portman, and Rand Paul to express opposition to a recent Medicare proposal that would remove $150 million in funding for anti-cancer   (Read More)

This month is National Colon Cancer Awareness Month. According to the American Cancer Society (ACS), colon cancers (of the colon and rectum) are the country’s “third leading cause of cancer death among men and women.” Although   (Read More)

OHC medical oncologist Dr. David Waterhouse, Chair of Clinical Research, was recognized as the winner in the Innovator category at the Cincinnati Business Courier 2016 Health Care Heroes Award Banquet. In front of over 400 attendees, Dr. Waterhouse   (Read More)

Lung cancer is the second most common cancer in both men and women in the United States, claiming an estimated 158,040 Americans in 2015 according to the American Lung Association. Cigarette smoking causes most lung cancers, and high levels of   (Read More)

It is with mixed feelings that OHC announces the retirement of our beloved and much appreciated Dr. John A. Bismayer, M.D. His last day is Mon., Feb. 8, 2016. His medical career has spanned close to four decades and his time with OHC has been   (Read More)

Today, the OHC team and our patients are uniting with supporters from around the world in the fight against cancer as part of the Union for International Cancer Control’s (UICC) celebration of World Cancer Day. World Cancer Day rallies as many   (Read More)

There are many misperceptions about clinical trials and the benefits they provide individuals battling cancer. As the leading provider of clinical trials in the tri-state area, OHC continues to invest resources in providing and educating the   (Read More)

Thirty-five abstracts authored by members of the Sarah Cannon Blood Cancer Network were presented at the recent American Society of Hematology (ASH) Meeting and Exposition. OHC expert hematologists Dr. James H. Essell and Dr. Ed Faber were co-authors   (Read More)

We have seen significant progress in how cancer is treated this last year. Individualized and personalized therapy has revolutionized the treatment plan for many cancer types. Nivolumab, a new immunotherapy drug used to treat advanced non-squamous,   (Read More)

The American Cancer Society’s estimates for lung cancer in the United States for 2015 are: • About 221,200 new cases of lung cancer (115,610 in men and 105,590 in women) • An estimated 158,040 deaths from lung cancer (86,380 in men and 71,660   (Read More)

OHC was a major sponsor again this year for the Leukemia & Lymphoma Society “Light the Night” walk on Thurs., Oct. 15, at Sawyer Point. The annual event supports LLS’s mission to find a cure for blood cancer and to enhance the   (Read More)

OHC was a major sponsor again this year for the Leukemia & Lymphoma Society “Light the Night” walk on Thurs., Oct. 15, at Sawyer Point. The annual event supports LLS’s mission to find a cure for blood cancer and to enhance the   (Read More)

OHC recently received accreditation as an Oncology Medical Home from the Commission on Cancer (CoC). This recognition distinguishes OHC as one of the nation’s premier independent cancer practices as the accreditation was awarded to only nine   (Read More)